NO174850C - 6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
- Google Patents
6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
Info
Publication number
NO174850C
NO174850CNO923358ANO923358ANO174850CNO 174850 CNO174850 CNO 174850CNO 923358 ANO923358 ANO 923358ANO 923358 ANO923358 ANO 923358ANO 174850 CNO174850 CNO 174850C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/156,865external-prioritypatent/US4824959A/en
Publication of NO923358LpublicationCriticalpatent/NO923358L/no
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Priority to NO923358ApriorityCriticalpatent/NO174850C/no
Publication of NO923358D0publicationCriticalpatent/NO923358D0/no
Publication of NO174850BpublicationCriticalpatent/NO174850B/no
Publication of NO174850CpublicationCriticalpatent/NO174850C/no
NO923358A1988-02-181992-08-276-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
NO174850C
(no)
6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
Nya -(2-okso-2,4,5,6,7,7a -hexahydro-tieno(3,2-c)-5-pyridyl)fenylaettiksyraderivat, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
Foerfarande foer framstaellning av en terapeutiskt anvaendbar 2-(n-disubstituerad amino)-1,3,4,6,7,11b- hexahydro-2h-benso/a/kinolizin och i foerfarandet anvaendbar mellanprodukt.
6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav